In this commentary, Melanie Anderson discusses the use of paper-based dried sampling technologies and how they can provide opportunities to collect biological samples in the dried state, which involves significantly smaller sample volumes than traditional sample collection approaches.
In this editorial, the author discusses paper-based assays as an emerging technology in bioanalysis, as well as point-of care diagnostics and treatment.
This article discusses membrane-based distillation ion chromatography as a new bioanalytical method. Find out more in this article from Bioanalysis.
In this installment of Robert MacNeill’s (Envigo) column, Robert discusses the instability of drugs within samples and how to balance their instability against absorptive loss.
Current thinking on quantification of protein therapeutic pharmacokinetics and protein biomarkers in clinical studies
In this commentary, Kate Peng discusses the current thinking on quantification of protein therapeutic pharmacokinetics and protein biomarkers in clinical studies.
In this commentary, the authors discuss the benefits and challenges of using ‘ready-to-use’ cells from a frozen bank of uniform, tested, aliquots.
In December 2015, the Reid Bioanalytical Forum entered a new era with a new committee…
An editorial on where the Bioanalysis spotlight entitled – Microsampling: the road ahead has led to two years on.
In this Editorial, Tim Sangster takes a personal look at how microsampling has developed over the last couple of decades.
Press release summarizing recent Spotlight event on HRMS hosted by Bioanalysis Zone.